Related Experiment Video
Updated: Jun 28, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
[Chronic myeloproliferative diseases. Current therapeutic standards and new developments]
1Medizinische Klinik 5, Universitätsklinikum Erlangen, Erlangen, Deutschland.
Der Internist
|November 6, 2008
Summary
Chronic myeloproliferative diseases (CMPD) are slow-growing blood cancers. Current treatments focus on managing symptoms and preventing complications, with lifelong monitoring essential for patient care.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Context:
- Chronic myeloproliferative diseases (CMPD) are a group of hematologic malignancies characterized by indolent progression.
- Philadelphia-chromosome-positive chronic myeloid leukemia (Ph+ CML) has seen successful targeted therapy with imatinib.
- Philadelphia-chromosome-negative CMPD (Ph-negative CMPD) management traditionally involves cytoreduction and low-dose aspirin (ASS) to mitigate vascular risks.
Purpose:
- To outline the current understanding and management strategies for chronic myeloproliferative diseases.
- To differentiate treatment approaches based on Philadelphia chromosome status.
- To emphasize the chronic nature of CMPD requiring long-term care.
Summary:
- CMPD are characterized by slow growth and maintained function of malignant cells.
- Targeted therapy has revolutionized Ph+ CML treatment.
- Ph-negative CMPD are managed with cytoreduction and low-dose aspirin to prevent vascular complications.
Impact:
- Highlights the need for lifelong surveillance and therapy in all CMPD patients.
- Underscores the importance of understanding molecular mechanisms for therapeutic advancements.
- Informs clinical practice regarding the management of indolent hematologic neoplasms.
More Related Videos
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...